Delivery Order SPE2DB22D1103-SPE2DB25FTKC4

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,261.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with an ultimate completion date of April 18, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract, indicating open...
This federal contract award, valued at $1,142.98, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 19, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,407.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 27, 2025. The contract covers the procurement of 4567039307 AMNESTEEM 40 MG CAPSULE 30S, which are likely pharmaceutical products. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $4,466.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a performance period ending on April 21, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,704.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a medical product, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is an order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,142.98 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $1,401.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of November 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of AMNESTEEM 40 MG CAPSULE 30S. The contract has a ceiling value of $2,603.25 and is a Firm Fixed Price Delivery Order that will run through August 21, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office Division, will be responsible for providing these prescription...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.27 Firm Fixed Price Delivery Order contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $2,712.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a medical product, and has a period of performance through February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTKC4
    Delivery Order

This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTKC4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication AMNESTEEM 40 MG CAPSULE 30S, with a firm fixed price ceiling value of $1,188.34 and a completion date of April 11, 2025.

The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely a delivery order under that larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:32 PM